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Abstract: On a global research expedition, over 500 bacterial strains inhibitory towards 
pathogenic bacteria were isolated. Three hundred of the antibacterial strains were assigned 
to  the  Vibrionaceae  family.  The  purpose  of  the  present  study  was  to  investigate  the 
phylogeny  and  bioactivity  of  five  Vibrionaceae  strains  with  pronounced  antibacterial 
activity.  These  were  identified  as  Vibrio  coralliilyticus  (two  strains),  V.  neptunius 
(two strains), and Photobacterium halotolerans (one strain) on the basis of housekeeping 
gene sequences. The two related V. coralliilyticus and V. neptunius strains were isolated 
from distant oceanic regions. Chemotyping by LC-UV/MS underlined genetic relationships 
by showing highly similar metabolite profiles for each of the two V. coralliilyticus and 
V. neptunius strains, respectively, but a unique profile for P. halotolerans. Bioassay-guided 
fractionation identified two known antibiotics as being responsible for  the antibacterial 
activity; andrimid (from V. coralliilyticus) and holomycin (from P. halotolerans). Despite 
the isolation of already known antibiotics, our findings show that marine Vibrionaceae are 
a  resource  of  antibacterial  compounds  and  may  have  potential  for  future  natural 
product discovery.  
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1. Introduction  
Bioactive  secondary  metabolites  are  believed  to  play  a  key  role  in  microbial  interactions  by 
mediating  antagonistic  activity  and  intercellular  communication  [1].  In  addition,  many  microbial 
natural products have biotechnological potential as antibiotics, biosurfactants, antifungal, or anticancer 
agents [2]. Sequences of microbial genomes revealed that only a small fraction of the natural product 
diversity is known, highlighting the potential for finding novel bioactive compounds in environmental 
microorganisms [3]. The need for novel antimicrobials to combat increasing antibiotic resistances in 
pathogenic  bacteria  has  stimulated  the  exploration  of  other  than  the  traditional  sources,  such  as 
terrestrial actinomycetes or fungi [4]. 
The marine environment harbors bacteria with antagonistic traits [5,6], and marine microorganisms 
are a potential source of novel antimicrobials [7]. Antagonistic marine bacteria have been isolated from 
surface [8] and deep waters [9], but the majority originated from biotic surfaces such as sponges [10], 
zooplankton  and  macroalgae  [8,11],  corals  [12],  and  bryozoans  [13].  Bioactive  bacterial  strains 
predominantly  belong  to  Pseudoalteromonas  spp.  [14],  the  Roseobacter  clade  [15],  and 
Actinobacteria [16]. A number of marine-derived antimicrobials have been characterized in greater 
detail, including halogenated [17] and sulfuric [18] compounds, depsipeptides [19] and lipopeptides [20], 
glycolipids [21], as well as high molecular weight structures such as amino acid oxidases [22]. 
Also  the  Vibrionaceae  family,  Gram-negative  Gammaproteobacteria  ubiquitous  in  marine  and 
brackish environments [23], harbors strains with antagonistic activity [8]. The family comprises eight 
genera, with Vibrio and Photobacterium constituting the majority of species. To date, Vibrionaceae 
have primarily been investigated due to their pathogenic potential to humans and aquatic animals, but 
they also occur in commensal or symbiotic associations with eukaryotic organisms [23]. While the 
abundance  of  Vibrionaceae  in  nutrient-rich  microenvironments  such  as  chitinous  zooplankton  is 
potentially  related  to  a  superior  nutrient  utilization  based  on  their  metabolic  versatility  [24], 
antagonism of competing bacteria through production of antimicrobial compounds may also contribute 
to a selective advantage. Antimicrobials from Vibrio spp. can reduce the number of other microbial 
community  members  and  influence  microscale  variations  in  competing  bacterial  populations  [6]. 
Antibacterial  activities  have  been  described  from  V.  alginolyticus  [25],  V.  parahaemolyticus  [26], 
V. anguillarum [27], and several unidentified Vibrio spp. [28,29]. However, the nature and frequency 
of antagonism among vibrios is still largely unknown, and only a few antibiotic Vibrio compounds 
have been structure elucidated to date [30,31]. 
The present study describes the analysis of bioactive Vibrionaceae strains collected during a global 
marine  expedition [8]. The purpose was to  (i)  provide phylogenetic and chemical analyses of the 
strains  with  strongest  antibacterial  activity;  (ii)  characterize  their  bioactivity  depending  on  culture 
conditions;  and  (iii)  isolate  and  elucidate  the  structure  of  bioactive  metabolites.  We  report  the Mar. Drugs 2010, 8  
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identification  of  five  Vibrionaceae  strains  with  pronounced  antibacterial  activity,  the  use  of 
chemotyping to support genetic identification, and the structures of two antibacterial compounds.  
2. Results and Discussion 
2.1. Selection of Strains with Pronounced Antibacterial Activity 
Three  hundred  and  one  Vibrionaceae  strains  were  isolated  during  a  global  marine  expedition 
(http://www.galathea3.dk/uk) based on their ability to antagonize the fish pathogen Vibrio anguillarum 
strain 90-11-287 [8]. After being stored at −80 °C  for between six and 12 months, all strains were 
retested for antibacterial activity against V. anguillarum strain 90-11-287 and the human pathogen 
Staphylococcus aureus strain 8325 by spotting colony mass on pathogen-seeded agar [8]. Activity was 
assessed  by  the  formation  of  clearing  zones  around  spotted  colony  mass.  From  301  strains,  only 
138 retained  antibacterial  activity,  being  a  small  fraction  compared  to  other  antagonistic  marine 
bacteria [32,33]. One hundred strains causing pronounced inhibition (diameter of clearing zones larger 
than  10 mm)  were  retested  using  the  same  set-up,  resulting  in  a  subselection  of  39  strains  with 
reproducible strong antibacterial activity when spotted on pathogen-seeded agar. This subselection was 
inoculated in liquid cultures and extracted with ethyl acetate to determine if antibacterial compounds 
were extractable with organic solvent. Activity was seen in ethyl acetate extracts from five strains, 
which were selected for further analyses. The five bioactive strains originated from different surface 
samples collected in distant oceanic regions (Figure 1).  
Figure  1.  Site  of  isolation,  source,  and  species  identification  of  five  bioactive  marine 
Vibrionaceae. Strains were identified to the species level by sequence analysis of several 
housekeeping genes (see below).  
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2.2. Phylogenetic Identification and Chemotyping of Strains 
All  strains  investigated  in  the  present  study  had  previously  been  assigned  to  the  Vibrionaceae 
family based on 16S rRNA gene similarities [8]. However, the 16S rRNA gene is highly conserved 
among the Vibrionaceae and is not well suited for identification to the species level [34]. Therefore, 
additional sequence analyses of three housekeeping genes (recA, rpoA, and toxR) were performed. 
These  genes  encode  constitutively  expressed  proteins  and  are  suitable  for  phylogenetic  studies  of 
Vibrionaceae [34,35]. On the basis of recA and rpoA sequence similarities, strains S2052 and S4053 
were  identified  as  Vibrio  coralliilyticus,  S2394  and  S4051  as  Vibrio  neptunius,  and  S2753  as 
Photobacterium  halotolerans  (Figure  1).  The  toxR  gene  was  less  suited  for  general  species 
identification due to its high variability even in closely related vibrios, as well as comparatively few 
toxR  sequence  data  available  in  public  gene  libraries  [36].  However,  multiple  alignments  and  
neighbor-joining analyses of toxR sequences provided the best phylogenetic resolution for determining 
the relationship between the five strains (Figure 2). The usefulness of toxR for species discrimination 
was  consistent  with  previous  reports  [35].  LC-UV/MS  metabolite  profiles  underlined  the  close 
relationship  between  V. coralliilyticus  S2052/4053 and V. neptunius S2394/4051, respectively.  The 
evolutionary  distance  of  P. halotolerans  S2753  to  the  other  strains  was  reflected  by  a  unique 
metabolite profile (Figure 2). All five strains were consistent in their metabolite production in separate 
cultivations over a one-year interval.  
Several metabolites were produced by all V. coralliilyticus and V. neptunius strains, for instance 
those related to the peaks at retention times Rt = 11.08 and 12.03 min (Figure 2). Although they are 
different  species,  V.  coralliilyticus  and  V.  neptunius  are  closely  related  vibrios  with  only  2–3% 
sequence variation in the recA and rpoA genes (data not shown), signifying why biosynthetic pathways 
are shared between the species. Based on their molecular formulas, UV, and MS characteristics [37], 
most of the metabolites produced by both species were assigned as smaller peptides (m/z 300–500), a 
class of molecules commonly produced by marine culturable bacteria [38,39]. Despite the presence of 
shared metabolites between V. coralliilyticus and V. neptunius, clearly distinguishable peaks were seen 
as well. For instance, the major peak at retention time Rt = 10.02 min (MW 479 Da) was only seen in the 
two V. coralliilyticus, and the peak at Rt = 10.11 min (MW 493 Da) only in the two V. neptunius strains.  
The  metabolites  produced  by  P.  halotolerans  S2753  comprised  a  series  of  larger  peptides  
(m/z 500–900) [40]. The large peak at Rt = 1.70 min (MW 213 Da) displayed a unique UV spectrum 
characteristic of that of a highly conjugated system. However, this peak could not be ascribed to any 
known compound or compound class based on LC-UV/MS data alone.  
Several metabolites (Rt = 4.70, 7.41, 8.60, 9.60, and 10.50 min) were found in all five strains and 
assigned as poly-β-hydroxybutyric acid polymers (PHB) of varying lengths (repeating unit n = 86 Da). 
This was verified by NMR for some of the compounds (data not shown). PHB are common bacterial 
storage compounds accumulated when growing on an excess carbon source [41]. 
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Figure  2.  Phylogenetic  and  chemical  relationship  between  five  bioactive  Vibrionaceae 
based on neighbor-joining analyses of aligned toxR gene sequences and LC-MS Total Ion 
Chromatograms (TIC). The scale bar relates to the number of base substitutions in toxR 
gene sequences (as displayed by branch lengths in the phylogenetic tree). 
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Chemotyping of prokaryotes has mostly been restricted to analyses of fatty acids and sugars [42], 
but we show that also the profiling of small molecules can be used for species discrimination. This 
highlights  the  usefulness  of  metabolomics  for  bacterial  classification,  adding  to  recent  work  of 
whole-cell laser desorption MALDI-TOF mass spectrometry for characterization of vibrios [43] and 
secondary metabolite profiling to assess the biosynthetic potential of marine Pseudoalteromonas [32]. 
While our study is limited to the analysis of only three species from the Vibrionaceae family, the 
isolation  of  two  genetically  and  chemically  closely  related  “strain  siblings”  from  distant  oceanic 
regions  indicated  that  production  of  certain  secondary  metabolites  is  a  preserved  trait.  Similar 
secondary metabolite profiles were also shown for marine actinomycetal Salinispora spp. [44] from 
distant  habitats.  Also,  all  Ruegeria  mobilis  strains  from  worldwide  locations  produced  the  same 
antibiotic, tropodithietic acid [33]. 
2.3. Bioassay-Guided Identification of Antibacterial Compounds 
V.  coralliilyticus  (strains  S2052  and  S4053)  and  P.  halotolerans  (S2753)  inhibited  both 
V. anguillarum  and  S.  aureus,  whereas  V.  neptunius  (strains  S2394  and  S4051)  only  inhibited 
V. anguillarum (Table 1). Antibacterial activity was highest in aerated cultures and detected after one, 
three, and five days of incubation. No significant difference in activity was seen between the tested 
culture media. 
Table 1. Inhibition of V. anguillarum strain 90-11-287 and S. aureus strain 8325 by ethyl 
acetate extracts from five marine Vibrionaceae. Antibacterial activity is displayed by the 
diameter of clearing zones (−: no activity; +: between 0 and 15 mm; ++: between 15 and 
30 mm; +++: over 30 mm). 
    Inhibition of  
Strain  Species  V. anguillarum  S. aureus 
S2052  V. coralliilyticus  +++  ++ 
S2394  V. neptunius  ++  − 
S2753  P. halotolerans  +++  ++ 
S4051  V. neptunius  ++  − 
S4053  V. coralliilyticus  ++  + 
The finding of bioactivity among marine Vibrionaceae underlined marine microorganisms being a 
source of antimicrobials. To our knowledge, none of the species investigated here have previously 
been studied with respect to their secondary metabolome including antibacterial compounds.  
To  identify  the  compounds  responsible  for  the  observed  activity,  large-scale  cultivations  and 
fractionations were undertaken for V. coralliilyticus S2052 and P. halotolerans S2753, representing 
two distant Vibrionaceae species with different metabolite profiles. All fractionation steps were guided 
by activity testing against V. anguillarum strain 90-11-287. 
Initial dereplication of S2052 by LC-UV/MS [37] and explorative solid-phase extraction (E-SPE) [45] 
indicated that andrimid (Rt = 10.02 min; Figure 2) could be responsible for the antibacterial activity. 
This compound (Figure 3a), a hybrid nonribosomal peptide-polyketide antibiotic, was first described 
from an insect endosymbiont [46] and later found in other microbial species [47,48] including marine Mar. Drugs 2010, 8  
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vibrios [29,31]. Pure andrimid was isolated for NMR analysis, and our data was in accordance with 
literature data [47]. Andrimid acts as an acetyl-CoA carboxylase inhibitor [49], and we extended its 
broad antibiotic spectrum [50] by showing inhibition of the bacterial pathogens Salmonella Enteritidis, 
Bacillus cereus, Yersinia enterolitica, Yersinia ruckeri, Vibrio harveyi, and Vibrio vulnificus (data not 
shown). Production of andrimid was also confirmed for the other isolated V. coralliilyticus strain, 
S4053. We furthermore speculate whether a recent report of antagonism in the V. coralliilyticus type 
strain  [12]  was  also  attributed  to  this  compound.  Previous  studies  have  revealed  almost  identical 
andrimid gene clusters and a transposase pseudogene in two producer species, suggesting horizontal 
gene transfer as the most likely explanation behind the cosmopolitanism of the antibiotic [51]. We 
hypothesize that such transfer is also the reason for its presence in V. coralliilyticus S2052 and S4053. 
Our  study  is  the  first  linking  andrimid  production  to  a  specific  Vibrio  species,  with  production 
occurring in two strains isolated from very different geographical regions and sources.  
The antibacterial compound of P. halotolerans S2753 was identified as holomycin (Rt = 1.70 min; 
Figure 2), a compound belonging to the pyrrothine class of antibiotics acting by interference with RNA 
synthesis [52]. Our NMR data (Figure 3b) was consistent with previous reports [53]. Holomycin has 
until now only been found in Gram-positive Streptomyces [54,55], and the present study is the first 
demonstrating production of this antibiotic in a Gram-negative heterotrophic bacterium. While parallel 
evolution  of  this  trait  is  possible,  horizontal  gene  transfer  is  the  more  likely  explanation  for  its 
occurrence  in  both  Vibrionaceae  and  actinomycetes.  We  extended  the  broad-spectrum  activity  of 
holomycin  [52]  by  showing  inhibition  of  the  bacterial  pathogens  Listeria  monocytogenes, 
Serratia marcescens, S. Enteritidis, B. cereus, Y. enterolitica, Y. ruckeri, V. harveyi, V. vulnificus and 
V. parahaemolyticus,  as  well  as  of  several  marine  strains  from  the  Roseobacter  and 
Pseudoalteromonas groups (data not shown). 
Figure 3. Structures of andrimid (a) and holomycin (b) isolated from marine Vibrionaceae. 
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dual  physiology,  being  antagonistic  against  other  prokaryotes  but  pathogenic  towards  higher 
organisms. Moreover, the production of antibiotics in several species suggests that these compounds 
may be of ecological importance [1]. 
This study highlights one of the challenges in natural product discovery. Despite major screening 
efforts for novel antimicrobials to be used in pharmaceutical, food, and aquaculture industries, only a 
limited  amount  of  compounds  have  been  discovered  in  recent  years  [58].  While  the  isolation  of 
culturable  bacteria  remains  a  promising  approach  [42]  and  the  secondary  metabolome  of  marine 
vibrios  has  not  been  extensively  studied,  we  only  isolated  known  compounds  despite  careful 
dereplication prior to any compound purification. Dereplication is apparently troubled by the high 
degree of gene transfer between distantly related bacteria such as Gram-positive actinomycetes and 
Gram-negative Proteobacteria [3]. Many compounds in natural product databases such as AntiBase [59] 
have similar masses (<5 ppm difference), so even the combination of UV/VIS spectra, accurate mass 
data  (<5  ppm),  and  E-SPE  [45]  is  not  sufficiently  discriminatory  for  these  organisms.  To  avoid 
isolation  of  redundant  chemistry,  dereplication  by  NMR  [60]  or  ultra  high-resolution  mass 
spectrometry  (<1  ppm)  with  high  isotope  accuracy  ratios  for  correct  elementary  composition 
determination [61] is imperative to exclude previously isolated compounds.  
3. Experimental Section  
3.1. Isolation of Bioactive Marine Vibrionaceae 
During a global research expedition (http://www.galathea3.dk/uk), marine bacterial strains were 
isolated  from  environmental  samples  and  screened  for  antagonistic  activity  against  a  pathogenic 
Vibrio anguillarum,  strain  90-11-287.  Three  hundred  and  one  bioactive  strains  were  identified  as 
Vibrionaceae  based  on  16S  rRNA  gene  similarities  [8].  Pure  cultures  of  strains  were  stored  in 
cryoprotectant solution at −80 °C  until being analyzed in the present study. 
3.2. Selection of Strains with Pronounced Antibacterial Activity 
All 301 strains were retested for antibacterial activity by spotting colony mass on agar seeded with 
either  V.  anguillarum  strain  90-11-287  or  S.  aureus  strain  8325.  Activity  was  assessed  by  the 
formation of clearing zones around spotted  colony mass. Selected active strains were grown  both 
stagnant and aerated (200 rpm) in 30 mL Marine Broth 2216 (Difco 279110) for 3 days at 25 °C  in 
250 mL  glass bottles. Cultures were  extracted with an equal volume of HPLC-grade ethyl acetate 
(EtOAc) for 30 min. The organic phase was transferred to fresh sample vials and evaporated under 
nitrogen until dryness. Extracts were redissolved in 1 mL of EtOAc and stored at −20 °C  until further 
analysis.  EtOAc  extracts  were  tested  in  a  well  diffusion  agar  assay  [62]  for  activity  against 
V. anguillarum strain 90-11-287 and S. aureus strain 8325.  
3.3. Phylogenetic Analysis 
Genomic DNA was extracted from 1-day cultures using the NucleoSpin Tissue Kit (Macherey-Nagel, 
Dü ren, Germany) according to the manufacturer's instructions. PCR for recA and toxR gene fragments 
was performed according to [35], and PCR for rpoA gene fragments according to [34]. PCR products Mar. Drugs 2010, 8  
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were checked by agarose gel electrophoresis and purified using the Wizard PCR Preps DNA Direct 
Purification System (Promega, Madison, USA) according to the manufacturer’s instructions. Obtained 
nucleotide sequences were edited using Chromas Lite (Technelysium, Australia) and aligned to its 
closest sequence relative [36]. The phylogenetic relationship between the five isolates was determined 
by  neighbor-joining  analyses  (1000  bootstrap  replicates)  of  nucleotide  and  amino  acid  alignments 
(translated using EMBOSS Transeq, http://www.ebi.ac.uk/Tools/emboss/transeq/) done in ClustalX. 
Gene sequences have been deposited at GenBank under the accession numbers HQ452614–452618 
(toxR), HQ452619–452623 (recA), and HQ452624–452628 (rpoA). 
3.4. Influence of Culture Conditions on Bioactivity 
The five strains with strongest antibacterial activity (S2052, S2394, S2753, S4051, and S4053) were 
grown both stagnant and aerated (200 rpm) at 25 °C  in either Marine Broth (MB) or Marine Minimal 
Medium  [63]  containing  0.4%  glucose  and  0.3%  casamino  acids  (MMM).  Per  strain  and  culture 
condition, three bottles were inoculated with 30 mL of medium each, of which each one was sampled 
after 1, 3, and 5 days of incubation. In addition, strains were grown in 30 mL sea salt solution (Sigma 
S9883; 40 g L
−1) with 0.4% glucose and 0.3% casamino acids for 3 days (200 rpm) at 25 ° C. EtOAc 
extracts were prepared as described above, and tested in a well diffusion agar assay [62] for activity 
against V. anguillarum strain 90-11-287 and S. aureus strain 8325. 
3.5. Chemotyping 
Liquid chromatography-diode array/mass spectrometry (LC-UV/MS) analyses were performed on 
dried EtOAc extracts redissolved in methanol (MeOH) from all tested culture conditions to visualize 
the array of produced molecules. In addition, 3-day MMM cultures were extracted and analyzed in 
biological triplicate. LC-UV/MS was performed on an Agilent 1100 liquid chromatograph with a diode 
array  detector  (Agilent,  Waldbronn,  Germany)  coupled  to  an  LCT  TOF  mass  spectrometer 
(Micromass, Manchester, UK) using a Z-spray ESI source. The separation was done on a Luna II C18 
column (50 mm ×  2 mm, 3 µm) (Phenomenex, Torrance, CA) fitted with a security guard system using 
a linear gradient starting from 15% acetonitrile (MeCN) in water (H2O) to 100% MeCN over 20 min at 
a  flow  rate  of  300  µL  min
−1.  Both  MeCN  (HPLC  grade)  and  H2O  were  buffered  with  20 mM 
HPLC-grade formic acid (FA). 
3.6. Isolation and Structural Elucidation of Antibacterial Compounds 
Strains S2052 and S2753 were grown in 20 L sea salt solution (Sigma S9883; 40 g L
−1) with 
0.4% glucose and 0.3% casamino acids for 3 days (100 rpm) at 25 ° C. On day 3, sterile Dianion 
HP20SS resin (Sigma-Aldrich, St. Louis, MO) was added to the broth (12 g of resin L
−1). After 24 h, 
the resin was filtered off and washed with H2O (2 ×  1 L), followed by extraction with MeCN/H2O 
(80/20 v/v; 2 ×  1500 mL).  
For S2052, all organic extracts were pooled, absorbed onto 90 g Sepra ZT C18 (Phenomenex), and 
dried before packing into a 100 g SNAP column (Biotage, Uppsala, Sweden) with pure resin (10 g) in 
the base. Using an Isolera flash purification system (Biotage), the extract was subjected to a crude Mar. Drugs 2010, 8  
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fractionation using a MeCN/H2O gradient (flow rate 30 mL min
−1) starting with 10% MeCN (10 min, 
isocratic), increasing to 100% MeCN (25 min) before washing with 100% MeCN (15 min). Fractions 
were automatically collected using UV detection (210 and 320 nm). The fraction with antibacterial 
activity (185 mg) was subjected to further purification on a Luna II C18 column (250 ×  10 mm, 5 μm) 
(Phenomenex) using a 45–70% MeCN/H2O gradient (buffered with 20 mM FA, flow rate 5 mL min
−1) 
over 20 minutes on a Gilson 322 liquid chromatograph with a 215 liquid handler/injector (BioLab, 
Risskov, Denmark). This yielded 7.6 mg of pure andrimid.  
For S2753, the MeCN/H2O extract from Dianion HP20SS extraction was evaporated until dryness 
on a rotary evaporator. The extract was redissolved in EtOAc, absorbed onto 5 g Isolute diol (Biotage), 
and added to a glass column with pure diol (95 g). A total of 12 fractions were collected from the diol 
column (100 g, 20 ×  350 mm) ranging from heptane, dichloromethane, EtOAc to pure MeOH, running 
under gravity. The fraction with antibacterial activity (172 mg, 100% EtOAc) was further separated on 
the Isolera flash purification system, on Sepra ZT C18 (10 g SNAP) using a MeCN/H2O gradient (flow 
rate 12 mL min
−1) starting with 5% MeCN increasing to 30% MeCN (12 min), quickly increasing to 
100% MeCN (10 min). Fractions were automatically collected using UV detection (210 and 380 nm). 
Pure holomycin (4.3 mg) was obtained after final purification on a Luna II C18 column (250 ×  10 mm, 
5 μm) (Phenomenex) using a MeCN/H2O (buffered with 20 mM FA) gradient from 7–37% MeCN 
over 17 min.  
NMR  spectra  were  recorded  on  a  Bruker  Avance  800  MHz  spectrometer  with  a  5  mm  TCI 
Cryoprobe at the Danish Instrument Center for NMR Spectroscopy of Biological Macromolecules, 
using standard pulse sequences. The NMR data used for the structural assignment of andrimid and 
holomycin were acquired in DMSO-d6 (ʴH 2.49 and δC 39.5 ppm). 
Optical rotation was measured on a Perkin Elmer Model 341 polarimeter (Perkin Elmer, Waltham, 
MA) (ʱD at 589 nm). 
Andrimid:  orange-yellow  amorphous  solid;  UV  (MeCN/H2O)  λmax  200  (100%),  280  (40%) nm; 
[ʱ]D
20 −62.9°  (c 0.24, MeOH); 
1H NMR ʴH ppm: 0.75 (3H, d, 6.7 Hz, H-4’), 0.80 (3H, d, 6.7 Hz, H-5’), 
1.07 (d, 7.2 Hz, 1H, H-6), 1.78 (3H, d, 6.7 Hz, H-8’’’), 2.30 (m, 1H, H-3’), 2.65 (1H, dd, 14.6, 6.2 Hz, 
H-2a’’), 2.77 (1H, dd, 14.6, 8.2 Hz, H-2b’’), 2.91 (m, 1H, H-4), 3.92 (d, 5.6 Hz, 1H, H-3), 4.62 (dd, 8.4, 
5.4 Hz, 1H, H-2’), 5.28 (1H, m, H-3’’), 5.90 (1H, m, H-7’’’), 6.01 (1H, d, 15.2 Hz, H-2’’’), 6.18 (1H, m, 
H-6’’’), 6.26 (1H, dd, 14.5, 11.4 Hz, H-4’’’), 6.53 (1H, dd, 14.5, 10.0 Hz, H-5’’’), 7.00 (1H, dd, 15.2, 
11.4 Hz, H-3’’’), 7.20 (1H, m, H-7’’), 7.29-7.31 (4H, m, H-5’’/H-6’’), 8.11 (1H, d, 8.4 Hz, NH-2’), 
8.42 (1H, d,  8.5 Hz, NH-3’’), 11.36  (  s, 1H, NH-1); 
13C NMR  ʴC ppm: 14.5 (C-6),  17.2 (C-4’),  
18.3 (C-8’’’), 19.4 (C-5’), 28.1 (C-3’), 39.0 (C-4), 41.9 (C-2’’), 57.8 (C-3), 63.1 (C-2’), 124.2 (C-2’’’), 
126.4 (C-5’’), 126.9 (C-7’’), 128.1 (C-4’’’), 128.2 (C-6’’), 131.5 (C-6’’’), 133.4 (C-7’’’), 139.0 (C-5’’’), 
139.4 (C-3’’’), 142.9 (C-4’’), 164.3 (C-1’’’), 169.9 (C-1’’), 173.8 (C-2), 180.0 (C-5), 203.9 (C-1’); 
HRESIMS m/z 479.2435 (calcd for C27H33N3O5, 479.2420). 
Holomycin: orange-yellow prisms; UV (MeCN/H2O) λmax 200 (100%), 280 (40%) nm; 
1H NMR 
ʴH ppm: 2.01 (s, 1H, H-9), 7.04 (s, 1H, H-1), 9.86 (s, 1H, NH-7), 10.69 (s, 1H, NH-3); 
13C NMR 
ʴC ppm:  22.4  (C9), 110.6 (C-1), 115.4 (C-5), 133.7  (C-2), 133.9  (C-6),  167.9 (C-4),  168.8  (C-8); 
HRESIMS m/z 213.9860 (calcd for C7H6N2O2S2, 213.9871). 
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4. Conclusions 
The present study adds to the knowledge of Vibrionaceae bioactivity and physiology by showing a 
worldwide occurrence of marine strains producing antibacterial compounds. In addition, we underlined 
that  chemotyping  can  support  gene-based  species  identification  and  help  resolving  phylogenetic 
relationships within a  genetically homogenous family such as the  Vibrionaceae. The discovery of 
known antibiotics that are also produced by evolutionary distant microbes suggests an involvement of 
horizontal  gene  transfer,  and  indicates  that  these  compounds  are  fundamental  to  compete  and 
communicate  in  the  natural  habitat.  The  cosmopolitanism  of  identical  antibiotics  has  major 
implications for natural product discovery strategies and stresses the need for careful dereplication in 
the initial stages of screening. An alternative approach could be the screening for largely untested 
bioactivities, for instance, interference with quorum sensing or modulation of gene expression. 
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